- Quality of life in patients treated for COVID-19–associated mucormycosis at a tertiary care hospital
-
Kumar P, UR RR, Roy N, Agrawal D, Ahmad S, Bhavana K
- KMID: 2542098
- Osong Public Health Res Perspect.
- 2023 Apr;14(2):119-128.
- doi: 10.24171/j.phrp.2022.0307
Objectives: Coronavirus disease 2019 (COVID-19)–associated mucormycosis (CAM) has emerged as a formidable infection in patients with COVID-19. The aggressive management of CAM affects quality of life (QOL); thus, this study was... -
- CITED
-
- Close
- SHARE
-
- Close
